Wen X#, Zeng X#, Shi C, Liu J, Zhang Y, Shi M, Li J, Chen H, Zhuang R, Chen X*, Zhang X*, Guo Z*. Optimum combination of radiopharmaceuticals-basedtargeting-triggering-therapy effect and PD-L1 blockade immunotherapy. AdvancedTherapeutics, 2023, 6. -北京协和医院 - 协和医院,北京协和医院,協和醫院,北京协和医院首页,北京协和医院电话,协和,協和,医院,醫院,北京協和醫院,北京协和医院妇科,北京协和医院地址,挂号

Wen X#, Zeng X#, Shi C, Liu J, Zhang Y, Shi M, Li J, Chen H, Zhuang R, Chen X*, Zhang X*, Guo Z*. Optimum combination of radiopharmaceuticals-basedtargeting-triggering-therapy effect and PD-L1 blockade immunotherapy. AdvancedTherapeutics, 2023, 6.

时间：2024.04.22 发布来源：本站原创

Xuejun Wen#, Xinying Zeng#, Changrong Shi, Jia Liu, Yiren Zhang, Mengqi Shi, Jingchao Li,Haojun Chen, Rongqiang Zhuang, Xiaoyuan Chen*, Xianzhong Zhang*, ZhideGuo*. Optimum combination of radiopharmaceuticals-basedtargeting-triggering-therapy effect and PD-L1 blockade immunotherapy. AdvancedTherapeutics, 2023, 6, 2200193. https://doi.org/10.1002/adtp.202200193

上一条： Wang T, Xu P*, Fa...

下一条： Zhang Y, Wen X, W...